A citation-based method for searching scientific literature

Kenneth B Gordon, Bruce Strober, Mark Lebwohl, Matthias Augustin, Andrew Blauvelt, Yves Poulin, Kim A Papp, Howard Sofen, Lluís Puig, Peter Foley, Mamitaro Ohtsuki, Mary Flack, Ziqian Geng, Yihua Gu, Joaquin M Valdes, Elizabeth H Z Thompson, Hervé Bachelez. Lancet 2018
Times Cited: 278

Craig L Leonardi, Alexa B Kimball, Kim A Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T Dooley, Kenneth B Gordon. Lancet 2008
Times Cited: 1170

List of shared articles

Times cited

Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year.
Najeeda Yasmeen, Laura M Sawyer, Kinga Malottki, Lars-Åke Levin, Eydna Didriksen Apol, Gregor B Jemec. J Dermatolog Treat 2022

Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator-controlled VOYAGE 1/2 trials.
Sang Woong Youn, Dae Young Yu, Tae Yoon Kim, Byung Soo Kim, Seung Chul Lee, Jeung Hoon Lee, Yong-Beom Choe, Joo-Heung Lee, Jee-Ho Choi, Joo Young Roh,[...]. J Dermatolog Treat 2022

PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines.
Isabel Belinchón Romero, Esteban Dauden, Carlos Ferrándiz Foraster, Álvaro González-Cantero, Jose Manuel Carrascosa Carrillo. J Dermatolog Treat 2022

Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trial.
D Thaçi, K Eyerich, A Pinter, M Sebastian, K Unnebrink, S Rubant, D A Williams, P Weisenseel. Br J Dermatol 2022

Novel Therapeutic Target(s) for Psoriatic Disease.
Vishal Thakur, Rahul Mahajan. Front Med (Lausanne) 2022

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis.
Craig L Leonardi, Kyoungah See, Russel Burge, Zhuoer Sun, Ying Zhang, Lotus Mallbris, Alyssa Garrelts, Richard B Warren. Adv Ther 2022

Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis.
Karine Rodríguez-Fernández, Víctor Mangas-Sanjuán, Matilde Merino-Sanjuán, Antonio Martorell-Calatayud, Almudena Mateu-Puchades, Mónica Climente-Martí, Elena Gras-Colomer. Pharmaceutics 2022

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach, Laurence Le Cleach. Cochrane Database Syst Rev 2022

Break on through: The role of innate immunity and barrier defence in atopic dermatitis and psoriasis.
H C Hawerkamp, C M R Fahy, P G Fallon, C Schwartz. Skin Health Dis 2022

A Systematic Review with Meta-Analysis of Comparative Efficacy and Safety of Risankizumab and Ustekinumab for Psoriasis Treatment.
Qianying Yu, Xiaopei Ge, Mingyi Jing, Xiongfei Mi, Jing Guo, Min Xiao, Qing Lei, Mingling Chen. J Immunol Res 2022

Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry.
Abby S Van Voorhees, Marc A Mason, Leslie R Harrold, Ning Guo, Adriana Guana, Haijun Tian, Vivian Herrera, Bruce E Strober. J Dermatolog Treat 2021

Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry.
Abby S Van Voorhees, Marc A Mason, Leslie R Harrold, Ning Guo, Adriana Guana, Haijun Tian, Vivian Herrera, Bruce E Strober. J Dermatolog Treat 2021

Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.
Vineet S Rolston, Jessica Kimmel, Violeta Popov, Brian P Bosworth, David Hudesman, Lisa B Malter, Simon Hong, Shannon Chang. Dig Dis Sci 2021

Placebo Response in Phase 3 Trials of Systemic Therapies for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis.
Danni Ambikaibalan, Anna Sophie Quaade, Anne-Sofie Halling, Jacob P Thyssen, Alexander Egeberg. Dermatology 2021